X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (588) 588
Book Review (111) 111
Publication (79) 79
Newsletter (40) 40
Book Chapter (8) 8
Conference Proceeding (4) 4
Newspaper Article (4) 4
Book / eBook (1) 1
Dissertation (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
anidulafungin (622) 622
index medicus (372) 372
caspofungin (315) 315
humans (280) 280
micafungin (239) 239
microbiology (211) 211
pharmacology & pharmacy (205) 205
echinocandins (198) 198
antifungal agents - pharmacology (180) 180
fluconazole (154) 154
infectious diseases (153) 153
antifungal agents - therapeutic use (144) 144
echinocandins - pharmacology (125) 125
invasive candidiasis (122) 122
voriconazole (120) 120
amphotericin-b (116) 116
echinocandin (111) 111
antifungal agents (107) 107
male (105) 105
microbial sensitivity tests (101) 101
echinocandins - therapeutic use (96) 96
candida - drug effects (95) 95
candidiasis (94) 94
candida (93) 93
female (93) 93
candidemia (91) 91
candidiasis - drug therapy (90) 90
animals (89) 89
bacterial infections and mycoses (86) 86
pharmacokinetics (86) 86
susceptibility (78) 78
antifungal agents - pharmacokinetics (67) 67
antifungal agents - administration & dosage (65) 65
epidemiology (65) 65
middle aged (63) 63
mycoses (62) 62
mycology (60) 60
candidiasis - microbiology (59) 59
research (58) 58
amphotericin b (57) 57
adult (56) 56
health aspects (55) 55
infectious disease (55) 55
posaconazole (55) 55
in-vitro activity (52) 52
mycoses - drug therapy (52) 52
aged (51) 51
antifungal agents - adverse effects (51) 51
echinocandins - administration & dosage (51) 51
resistance (51) 51
liposomal amphotericin-b (50) 50
echinocandins - pharmacokinetics (47) 47
drug resistance, fungal (46) 46
itraconazole (46) 46
management (45) 45
candida albicans - drug effects (44) 44
treatment outcome (44) 44
infections (43) 43
analysis (42) 42
invasive fungal-infections (42) 42
fungal infections (41) 41
internal medicine (41) 41
antifungal (40) 40
candidiasis, invasive - drug therapy (40) 40
aspergillosis (39) 39
esophageal candidiasis (39) 39
lipopeptides (39) 39
aspergillus (38) 38
candida - isolation & purification (38) 38
drug therapy (38) 38
fungal-infections (38) 38
echinocandins - adverse effects (37) 37
albicans (36) 36
candida albicans (36) 36
efficacy (35) 35
infection (35) 35
aspergillosis - drug therapy (34) 34
immunology (34) 34
mortality (34) 34
pharmacology (33) 33
antifungal susceptibility (32) 32
care and treatment (32) 32
in-vitro (32) 32
blood-stream infections (31) 31
drug interactions (31) 31
polycyclic compounds (31) 31
spp (31) 31
antifungals (30) 30
lipopeptides - pharmacology (30) 30
disease models, animal (29) 29
dosage and administration (29) 29
therapy (29) 29
invasive aspergillosis (28) 28
mice (28) 28
surveillance (28) 28
adolescent (27) 27
aged, 80 and over (27) 27
candida glabrata - drug effects (27) 27
candidemia - drug therapy (27) 27
child (27) 27
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (553) 553
Spanish (47) 47
French (22) 22
German (12) 12
Polish (3) 3
Estonian (2) 2
Korean (2) 2
Chinese (1) 1
Italian (1) 1
Russian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of Pharmacotherapy, ISSN 1060-0280, 07/2012, Volume 46, Issue 7-8, pp. 1086 - 1096
Journal Article
Archivos Argentinos de Pediatria, ISSN 0325-0075, 08/2017, Volume 115, Issue 4, pp. 374 - 376
Journal Article
Diagnostic Microbiology & Infectious Disease, ISSN 0732-8893, 06/2019, Volume 94, Issue 2, pp. 155 - 156
This study evaluated combinations of amphotericin B with anidulafungin, caspofungin, and micafungin against 30 clinical isolates of following the CLSI M27-A3... 
Cryptococcus spp | Amphotericin B | Anidulafungin | Micafungin | Synergism | Caspofungin
Journal Article
BMC Systems Biology, ISSN 1752-0509, 08/2019, Volume 13, Issue 1, pp. 40 - 40
It was highlighted that the original article [1] contained errors in the figures and their legends and by extension the in-text figure citations. This... 
Pneumonia | Models | Anidulafungin | Bacterial pneumonia | Analysis | Caspofungin | Index Medicus
Journal Article
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, ISSN 0066-4804, 07/2019, Volume 63, Issue 7
A two-compartment pharmacokinetic (PK) population model of anidulafungin was fitted to PK data from 23 critically ill patients (age, 65 years [range, 28 to 81... 
anidulafungin | MICAFUNGIN | Candida | pharmacokinetics/pharmacodynamics | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | critical care unit | Monte Carlo simulation
Journal Article
12/2010
Invasive fungal infections are on the rise. Amphotericin B and azole antifungals have been the mainstay of antifungal therapy so far. The high incidence of... 
invasive aspergillosis | Anidulafungin | esophageal candidiasis | echinocandins | invasive candidiasis | caspofungin | micafungin | candidemia
Web Resource
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 07/2018, Volume 62, Issue 7
In 2025, approximately one out of five adults will be obese. Physiological changes associated with obesity have been shown to influence the pharmacokinetics of... 
Echinocandin | Antifungal therapy | Obese | Anidulafungin | Modeling | antifungal therapy | anidulafungin | modeling | echinocandin | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | obese
Journal Article
Therapeutics and Clinical Risk Management, ISSN 1176-6336, 2007, Volume 3, Issue 1, pp. 71 - 97
Journal Article
Journal Article
FEMS Microbiology Letters, ISSN 0378-1097, 06/2018, Volume 365, Issue 12
The present study investigates the optimization of tannase production from Aspergillus nidulans for various physicochemical parameters and harvests tannase for... 
A. nidulans | Antimicrobial | Anti-biofilm | Antioxidant | Tannase | antimicrobial | antioxidant | SOLID-STATE FERMENTATION | ANIDULAFUNGIN | PSEUDOMONAS-AERUGINOSA | MICROBIOLOGY | tannase | anti-biofilm
Journal Article
Journal Article
Annals of Internal Medicine, ISSN 0003-4819, 01/2015, Volume 162, Issue 2, pp. 81 - 89
Journal Article
Journal Article
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 2018, Volume 73, Issue 11, pp. 3063 - 3067
Background: Rezafungin is an investigational echinocandin under development for the treatment and prevention of invasive fungal infections, with a long... 
MURINE MODEL | CASPOFUNGIN | INFECTIOUS DISEASES | MICAFUNGIN | CANDIDA | ANIDULAFUNGIN | RATIONALE | ANTIFUNGAL PROPHYLAXIS | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | LONG-ACTING ECHINOCANDIN
Journal Article
International Journal of Infectious Diseases, ISSN 1201-9712, 09/2019, Volume 86, pp. 142 - 146
To describe the pharmacokinetic (PK) profile of anidulafungin and to evaluate its concentration in the peritoneal fluid (PF) of patients suspected of suffering... 
Anidulafungin | Candida peritonitis | Pharmacokinetics | Critically ill patients | Peritoneal fluid | Index Medicus
Journal Article
Revista Iberoamericana de Micologia, ISSN 1130-1406, 07/2017, Volume 34, Issue 3, pp. 175 - 179
Background Current therapeutic strategies have a limited efficacy against Candida biofilms that form on the surfaces of biomedical devices. Few studies have... 
Polytetrafluoroethylene | Amphotericin B | Anidulafungin | Biofilm | Titanium | Candida tropicalis
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 01/2019, Volume 63, Issue 1
Echinocandins are front-line agents for treatment of invasive candidiasis. There are no reported agent-specific differences in Candida mutational frequency of... 
Echinocandin | Anidulafungin | Caspofungin | Candida glabrata | Micafungin | Mutational frequency | FKS | anidulafungin | echinocandin | SUSCEPTIBILITY | mutational frequency | MICROBIOLOGY | caspofungin | FAILURE | MUTANTS | RESISTANCE | PHARMACOLOGY & PHARMACY | CASPOFUNGIN MICS | OUTCOMES | SELECTION | micafungin | INVASIVE CANDIDIASIS
Journal Article